Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BROOKS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Moderate ROE but improving trend
Strong revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Negative
Weak price momentum
Company's earnings are of low quality
Low dividend yield
Neutral
Low operating margin but improving trend
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
BROOKS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BROOKS Bulk, Block & Insider Trades
BROOKS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
Rights issue
Rights issue(1 new shares @ 75 INR for 16 existing shares)"Rights ISIN INE650L20011CINS Y0R84Z113SEDOL BR1YGP6." Ex-date: 28th Jul 2023 Announced on: 25th Jan 2023
Rights issue(9 new shares @ 20 INR for 20 existing shares) Ex-date: 11th Feb 2020 Announced on: 31st Jan 2020
Company Profile
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company’s segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, a... Read More
Key personnel
Mr. Prashant Rathi
Chief Financial Officer
Ms. Krutika Mohan Rane
Compliance Officer, Company Secretary
Mr. Rajesh MahajanD
Executive Director
Mr. Bhushan Singh RanaD
Additional Executive Director
Mr. Jitendra Pratap SinghD
Whole-Time Director
Dr. Durga Sankar MaityD
Additional Director
Mr. Lalit MahajanD
Additional Non-Executive Independent Director
Mr. Manav MahajanD
Additional Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Brooks Laboratories Ltd.?
The current share price of Brooks Laboratories Ltd. is ₹ 74.27 as of 09 Jan 2026.
What is the PE ratio of Brooks Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Brooks Laboratories Ltd. is 18.97 as of the latest financial data.
What is the ROE and ROCE of Brooks Laboratories Ltd.?
Brooks Laboratories Ltd. has a Return on Equity (ROE) of 13.19% and a Return on Capital Employed (ROCE) of 6.30% as per the latest financial reports.
What is the market cap of Brooks Laboratories Ltd.?
The market capitalization of Brooks Laboratories Ltd. stands at ₹ 218.78 Cr.
What is the dividend yield of Brooks Laboratories Ltd.?
The dividend yield of Brooks Laboratories Ltd. is 0.00% based on the current market price.
What is the RSI of Brooks Laboratories Ltd.?
The Relative Strength Index (RSI) of Brooks Laboratories Ltd. is 28.48.
What is the FII and DII holding in Brooks Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 0.09% and Domestic Institutional Investors (DII) hold 9.90% of Brooks Laboratories Ltd. shares.
What sector does Brooks Laboratories Ltd. belong to?
Brooks Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Brooks Laboratories Ltd. stock?
The beta of Brooks Laboratories Ltd. stock is 1.16, indicating its volatility relative to the broader market.
